| Name | Title | Contact Details |
|---|
Since 1996, Principals of Clearwater Living have been actively engaged in the ownership, operation, and development of high-quality senior living communities nationwide. More specifically, the Principals of Clearwater have been an integral part of creating various senior living platforms for operators as part of senior management. In 2011, Clearwater Living was formed for the sole purpose of providing entitled land and developing senior living communities for operators and their financial stakeholders. By combining best practices learned and aligning with top-of-class industry professionals, Clearwater Living`s primary objective is to expedite the process of supplying innovative projects to meet the growing demand of active adult and senior living communities. To further that goal, Clearwater Living and Berkshire Group entered into a joint venture in 2016. Through the joint venture, Clearwater Living will strategically acquire, develop and operate a full range of senior housing communities (including a mix of active adult, independent living, assisted living and memory care) throughout the Western United States. CWL is comprised of a high-performance real estate team utilizing our collective imagination, ingenuity and inventiveness in everything we do. Our passion is to create and manage high-quality senior living communities uniquely positioned and designed to complement their community and neighborhood culture.
Always There Resources is a Glen Ellyn, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salus Surgical Group is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Body Zone is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.